ZBiotics
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$120k Valuation: $2.0m | Seed | ||
* |
| $2.3m | Seed |
* | $12.0m | Series A | |
Total Funding | $14.4m |
Related Content
Recent News about ZBiotics
EditZBiotics is a biotechnology company specializing in genetically engineered probiotics designed to break down acetaldehyde, a toxic byproduct of alcohol consumption. The company targets health-conscious consumers who seek to mitigate the negative effects of alcohol. Operating in the health and wellness market, ZBiotics employs a direct-to-consumer business model, selling its products primarily through its website. Revenue is generated through the sale of individual units and subscription plans. The company emphasizes transparency, responsibility, and a people-first approach, with ongoing research aimed at addressing other health challenges such as dairy intolerance, radiation exposure, and lead contamination in water.
Keywords: biotechnology, probiotics, acetaldehyde, alcohol, health, wellness, direct-to-consumer, transparency, research, subscription.